Mechanisms regulating protein stability of the Gli transcription factor
Gli 转录因子蛋白稳定性的调节机制
基本信息
- 批准号:7450815
- 负责人:
- 金额:$ 5.18万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-07-01 至 2009-06-30
- 项目状态:已结题
- 来源:
- 关键词:AffectBasal cell carcinomaBindingBiological AssayC-terminalCellsChimeric ProteinsComplexDataDevelopmentDominant-Negative MutationEpitheliumErinaceidaeFellowshipGoalsHair follicle structureHumanIn VitroIndividualKineticsLuciferasesMalignant NeoplasmsMass Spectrum AnalysisMediatingModelingMutation AnalysisN-terminalNamesProtein OverexpressionProteinsProteolysisRNA InterferenceRegulationRoleSKP Cullin F-Box Protein LigasesSerineSignal PathwaySignal TransductionSkinTechnologyTrans-ActivatorsUbiquitinUbiquitinationadapter proteinbasegain of functiongene inductionin vivokeratinocytemulticatalytic endopeptidase complexmutantpreventprotein degradationtooltranscription factorubiquitin ligaseubiquitin-protein ligase
项目摘要
DESCRIPTION (provided by applicant): Inappropriate Sonic hedgehog (Shh) target gene induction has been implicated in many human cancers, including skin Basal cell carcinomas (BCCs). Previous studies have shown that regulation of Shh signal reception in skin keratinocytes occurs in part by regulating Gli transcription factor protein stability. Preliminary data has demonstrated two regions of Gli that mediate destruction. C-terminal sequences contain a ubiquitin-proteasome destruction signal or degron that is recognized by the adapter protein, ¿TrCP, a ubiquitin ligase. However, the identity of the putative N-terminal degron and the complex that binds to it remains unknown. The goal of this proposal is to identify the N-terminal sequences and trans-acting factors that bind to it to mediate Gli protein degradation. We aim to: 1) Determine the minimal sequences that define the degron and are sufficient to confer protein instability to chimeric proteins via deletion mutant analysis and degradation assays. We will assess how known regulators of Shh signaling affect both the N and C terminal degrons; 2) Identify Gli1 N-terminal associated proteins via protein pull-down assays and mass spectrometry technology. We will characterize Gli1 N-terminal associated proteins in Gli1 protein stability and ubiquitination assays using loss and gain of function analyses.
描述(由申请人提供):不适当的 Sonic Hedgehog (Shh) 靶基因诱导与许多人类癌症有关,包括皮肤基底细胞癌 (BCC)。 先前的研究表明,皮肤角质形成细胞中Shh信号接收的调节部分是通过调节Gli转录因子蛋白稳定性来实现的。 初步数据表明 Gli 的两个区域可以介导破坏。 C 端序列包含泛素蛋白酶体破坏信号或降解决定子,可被接头蛋白 TrCP(一种泛素连接酶)识别。 然而,假定的 N 端降解决定子以及与其结合的复合物的身份仍然未知。 该提案的目标是鉴定 N 端序列和与其结合以介导 Gli 蛋白降解的反式作用因子。 我们的目标是:1)通过缺失突变体分析和降解测定确定定义降解决定子并足以赋予嵌合蛋白蛋白质稳定性的最小序列。 我们将评估已知的 Shh 信号调节因子如何影响 N 和 C 末端降解决定子; 2) 通过蛋白质下拉分析和质谱技术鉴定 Gli1 N 末端相关蛋白。 我们将使用功能丢失和获得分析来表征 Gli1 蛋白稳定性和泛素化测定中的 Gli1 N 末端相关蛋白。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ivette S. Estay其他文献
Ivette S. Estay的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ivette S. Estay', 18)}}的其他基金
Mechanisms regulating protein stability of the Gli transcription factor
Gli转录因子蛋白质稳定性的调节机制
- 批准号:
7204156 - 财政年份:2006
- 资助金额:
$ 5.18万 - 项目类别:
相似海外基金
Precision oncology to define basal cell carcinoma (BCC) with high-risk histopathological subtypes
精准肿瘤学定义具有高风险组织病理学亚型的基底细胞癌 (BCC)
- 批准号:
485125 - 财政年份:2023
- 资助金额:
$ 5.18万 - 项目类别:
Operating Grants
Analysis of intraoperative videos from basal cell carcinoma removal surgery
基底细胞癌切除手术术中视频分析
- 批准号:
574060-2022 - 财政年份:2022
- 资助金额:
$ 5.18万 - 项目类别:
University Undergraduate Student Research Awards
Developing Improved Models of Basal Cell Carcinoma to Evaluate Tumor-Drug Response
开发改进的基底细胞癌模型以评估肿瘤药物反应
- 批准号:
10518702 - 财政年份:2022
- 资助金额:
$ 5.18万 - 项目类别:
Optimization of topical formulations for the treatment of basal cell carcinoma using the Feldan Shuttle technology
使用 Feldan Shuttle 技术优化治疗基底细胞癌的局部制剂
- 批准号:
549971-2020 - 财政年份:2022
- 资助金额:
$ 5.18万 - 项目类别:
Applied Research and Development Grants - Level 3
Predicting drug response for basal cell carcinoma by comprehensive genomic analysis.
通过综合基因组分析预测基底细胞癌的药物反应。
- 批准号:
21K16898 - 财政年份:2021
- 资助金额:
$ 5.18万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Optimization of topical formulations for the treatment of basal cell carcinoma using the Feldan Shuttle technology
使用 Feldan Shuttle 技术优化治疗基底细胞癌的局部制剂
- 批准号:
549971-2020 - 财政年份:2021
- 资助金额:
$ 5.18万 - 项目类别:
Applied Research and Development Grants - Level 3
Characterizing Genetic Factors that Modulate Stage-Specific Basal Cell Carcinoma Tumorigenesis
表征调节阶段特异性基底细胞癌肿瘤发生的遗传因素
- 批准号:
10066547 - 财政年份:2020
- 资助金额:
$ 5.18万 - 项目类别:
Optimization of topical formulations for the treatment of basal cell carcinoma using the Feldan Shuttle technology
使用 Feldan Shuttle 技术优化治疗基底细胞癌的局部制剂
- 批准号:
549971-2020 - 财政年份:2020
- 资助金额:
$ 5.18万 - 项目类别:
Applied Research and Development Grants - Level 3
Characterizing Genetic Factors that Modulate Stage-Specific Basal Cell Carcinoma Tumorigenesis
表征调节阶段特异性基底细胞癌肿瘤发生的遗传因素
- 批准号:
10212968 - 财政年份:2020
- 资助金额:
$ 5.18万 - 项目类别:
Characterizing Genetic Factors that Modulate Stage-Specific Basal Cell Carcinoma Tumorigenesis
表征调节阶段特异性基底细胞癌肿瘤发生的遗传因素
- 批准号:
10430040 - 财政年份:2020
- 资助金额:
$ 5.18万 - 项目类别: